FDA Deputy Commissioner Friedman To Join Searle
This article was originally published in The Tan Sheet
Executive Summary
FDA Deputy Commissioner for Operations Michael Friedman, MD, is leaving the agency to join Monsanto's Searle division as senior VP-clinical affairs.
You may also be interested in...
FDA Senior Scientist Schwetz Named Acting Deputy Commissioner
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent successor for the office vacated by Michael Friedman, MD.
FDA Senior Scientist Schwetz Named Acting Deputy Commissioner
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent successor for the office vacated by Michael Friedman, MD.
FDA Senior Scientist Schwetz Named Acting Deputy Commissioner
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent successor for the office vacated by Michael Friedman, MD.